| Abel Yimer, MD | |
|
477 Mclaws Cir Ste 1, Williamsburg, VA 23185-6316 | |
| (757) 984-9675 | |
| (757) 470-5401 |
| Full Name | Abel Yimer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 477 Mclaws Cir Ste 1, Williamsburg, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053767392 | NPI | - | NPPES |
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
Athersys, Inc. today announced its financial results for the quarter ended June 30, 2010.
There is a growing global consensus that girls are central to global development. Yet issues relating to girls' sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls' and young women's sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
At the halfway mark, industry giant Anthem Blue Cross is holding on to a slim lead among health insurance providers with a 31% share of California's exchange market. The Covered California exchange released enrollment figures Tuesday for its 11 health plans from Oct. 1 to the end of December.
ARIAD Pharmaceuticals, Inc. today announced positive clinical data from an ongoing Phase 1 study of its investigational, pan-BCR-ABL inhibitor, AP24534, in patients with advanced hematological cancers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abel Yimer, MD 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-4000 | Abel Yimer, MD 477 Mclaws Cir Ste 1, Williamsburg, VA 23185-6316 Ph: (757) 984-9675 |
News Archive
Athersys, Inc. today announced its financial results for the quarter ended June 30, 2010.
There is a growing global consensus that girls are central to global development. Yet issues relating to girls' sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls' and young women's sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
At the halfway mark, industry giant Anthem Blue Cross is holding on to a slim lead among health insurance providers with a 31% share of California's exchange market. The Covered California exchange released enrollment figures Tuesday for its 11 health plans from Oct. 1 to the end of December.
ARIAD Pharmaceuticals, Inc. today announced positive clinical data from an ongoing Phase 1 study of its investigational, pan-BCR-ABL inhibitor, AP24534, in patients with advanced hematological cancers.
› Verified 3 days ago
Dr. Harold D Jones Iii, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4601 Ironbound Rd, Eastern State Hospital, Williamsburg, VA 23187 Phone: 757-253-5161 | |
Dr. Ralph R Dimattia, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Sentara Cir, Williamsburg, VA 23188 Phone: 757-984-7218 Fax: 757-984-7210 | |
William J Beneke, M.D Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 5215 Monticello Ave, Williamsburg, VA 23188 Phone: 757-229-1440 | |
Dr. Kathleen M Tylman, D.O. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 477 Mclaws Cir, Suite 1, Williamsburg, VA 23185 Phone: 757-208-0005 Fax: 757-208-0006 | |
Dr. Vicki Stone Wilhelm, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 137 Kingspoint Dr, Williamsburg, VA 23185 Phone: 757-220-2718 | |
David Gordon Hundt, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 227 Mclaws Cir, Williamsburg, VA 23185 Phone: 757-564-8182 Fax: 757-564-0077 |